Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

16
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
16
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.4K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.6K
The pathophysiology of pneumonia involves the following steps:
4.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

1.3K
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
1.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same author

Distinct Metabolic Signatures Linked to High-Resolution Computed Tomography Radiographic Phenotypes in Stable and Progressive Fibrotic Lung Disease.

Metabolites·2026
Same author

Severe community-acquired pneumonia: current concepts and controversies.

Intensive care medicine·2026
Same author

Metabolomic profiling reveals distinct lipid signatures in progressive versus stable fibrotic lung disease.

Metabolomics : Official journal of the Metabolomic Society·2025
Same author

The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae.

Current opinion in infectious diseases·2024
Same author

Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trial.

International journal of antimicrobial agents·2024

Related Experiment Video

Updated: Apr 20, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

2.1K

Ventilator-associated pneumonia: present understanding and ongoing debates.

Girish B Nair1, Michael S Niederman

  • 1Pulmonary and Critical Care Medicine, Winthrop-University Hospital, Mineola, NY, USA, gbnair@winthrop.org.

Intensive Care Medicine
|November 28, 2014
PubMed
Summary

Ventilator-associated pneumonia (VAP) diagnosis and treatment require careful consideration of antimicrobial stewardship. Combining clinical scores, biomarkers, and cultures aids in de-escalating antibiotic therapy for better patient outcomes.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.7K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

4.0K

Related Experiment Videos

Last Updated: Apr 20, 2026

Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

2.1K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.7K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

4.0K

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Ventilator-associated pneumonia (VAP) is a significant nosocomial infection, increasing healthcare resource utilization.
  • Recent advancements have updated understanding of VAP epidemiology, diagnosis, treatment, and prevention strategies.

Purpose of the Study:

  • To review current data on VAP diagnosis, treatment, and prevention.
  • To emphasize the importance of antimicrobial stewardship in managing VAP.

Main Methods:

  • Review of emerging data on VAP epidemiology and diagnosis.
  • Evaluation of diagnostic scoring systems (e.g., CPIS) and microbiological specimen analysis.
  • Assessment of ventilator-associated events (VAE) surveillance and preventive strategies like the 'ventilator bundle'.

Main Results:

  • Strict time-based VAP classification may lead to inappropriate antibiotic use.
  • A combined diagnostic approach with scoring systems, cultures, and biomarkers supports antimicrobial stewardship.
  • The new VAE surveillance definition shows limitations in diagnosing VAP.
  • Adjunct aerosolized antibiotics and ventilator bundles can aid VAP management but have implementation challenges.

Conclusions:

  • High morbidity and mortality associated with VAP persist.
  • In the absence of a gold standard, VAP treatment should follow guidelines and local resistance patterns.
  • Integrated diagnostic approaches can reduce antibiotic duration and facilitate de-escalation.